Level II, randomized controlled trial (RCT).

This study provides information that supports existing theories about how and why certain injuries occur during the throwing motion in baseball. The late cocking phase appears to be the critical point in the pitching motion, where higher levels of torque at the shoulder and elbow can result in increased risk of injury. Manipulation of pitching mechanics to alter these torque levels or using these measures to identify pitchers at risk may help decrease injury rates.

No abstract

The purpose of this study was to evaluate pitching mechanics between female softball pitchers with upper extremity pain and those without upper extremity pain. Specifically, the trunk, shoulder and elbow kinematics and shoulder kinetics during the change-up softball pitch were examined. Fifty-five collegiate softball pitchers participated, divided into those with upper extremity pain (20.0±1.3 yrs.; 174.4±6.9 cm; 82.9±12.4 kg; 11.1±2.6 yrs. of experience; n=23) and those who were pain-free (19.9±1.4 yrs.; 173.8±6.9 cm; 81.4±12.5 kg; 10.0±2.5 yrs. of experience; n=32). Pitching mechanics were obtained via the trakSTAR electromagnetic tracking system (Ascension Technologies, Inc., Burlington, VT, USA). Mann-Whitney U tests revealed significant differences in shoulder horizontal abduction at foot contact (0.014, 153,2.450) and trunk lateral flexion at ball release (0.012, 150,-2.515); and between shoulder distraction force at ball release (0.034, 168,-2.124). The pain group illustrated greater shoulder horizontal abduction at foot contact, less trunk lateral flexion towards the throwing side at ball release, and greater shoulder distraction at ball release than the pain-free group. The differences in trunk and shoulder kinematics, and shoulder kinetics between groups allows for insight into further studies examining injury pervasiveness in softball pitching.

No abstract

A statistically significant association between maximum pitch velocity and elbow injury was noted in this study, providing further support of existing theories about injury in baseball.

Background: There is a paucity of research regarding the relationship between fastpitch softball pitching mechanics and reported pain. Thus, understanding the pitching mechanics of athletes pitching with upper extremity pain and those pain free is paramount. Purpose: To examine lower extremity pitching mechanics, upper extremity kinetics, and upper extremity pain in National Collegiate Athletic Association (NCAA) Division I female softball pitchers. Study Design: Descriptive laboratory study. Methods: A total of 37 NCAA Division I female softball pitchers (mean age, 19.84 ± 1.28 years; mean height, 173.67 ± 7.77 cm; mean weight, 78.98 ± 12.40 kg) from across the United States were recruited to participate. Participants were divided into 2 groups: upper extremity pain (n = 13; mean age, 19.69 ± 1.18 years; mean height, 172.60 ± 11.49 cm; mean weight, 86.75 ± 13.02 kg) and pain free (n = 24; mean age, 19.91 ± 1.35 years; mean height, 174.26 ± 4.96 cm; mean weight, 74.78 ± 9.97 kg). An electromagnetic tracking system was used to obtain kinematic and kinetic data during the riseball softball pitch. Results: At foot contact ( F 3,33 = 7.01, P = .001), backward elimination regression revealed that stride length, trunk rotation, and center of mass (COM) significantly explained about 33% of variance with softball pitchers experiencing upper extremity pain (adjusted R 2 = 0.33). Conclusion: At foot contact, the kinematic variables of increased trunk rotation toward the pitching arm side, increased stride length, and a posteriorly shifted COM were associated with upper extremity pain in collegiate softball pitchers. Variables early in the pitching motion that do not set a working and constructive proximal kinetic chain foundation for the rest of the pitch to follow could be associated with breakdowns more distal in the kinetic chain, possibly increasing the susceptibility to upper extremity pain. Clinical Relevance: The identification of pitching mechanics associated with pain allows clinicians to develop exercises to avoid such mechanics. Avoiding mechanics associated with pain may help reduce the prevalence of pain in windmill softball pitchers as well as help coaches incorporate quantitative biomechanics into their instruction.

Background: Approximately 47 million people in the United States have been diagnosed with arthritis. Autologous platelet-rich plasma (PRP) injections have been documented to alleviate symptoms related to knee osteoarthritis (OA) in randomized controlled trials, systematic reviews, and meta-analyses. Autologous bone marrow aspirate concentrate (BMC) injections have also emerged as a treatment option for knee OA, with a limited clinical evidence base. Purpose: To compare the efficacy of BMC to PRP for the treatment of knee OA regarding pain and function at multiple time points up to 12 months after an injection. We hypothesized that BMC will be more effective in improving outcomes in patients with knee OA. Study Design: Randomized controlled trial; Level of evidence, 2 Methods: A total of 90 participants aged between 18 and 80 years with symptomatic knee OA (Kellgren-Lawrence grades 1-3) were randomized into 2 study groups: PRP and BMC. Both groups completed the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and subjective International Knee Documentation Committee (IKDC) questionnaires before and 1, 3, 6, 9, and 12 months after a single intra-articular injection of leukocyte-rich PRP or BMC. Results: There were no statistically significant differences in baseline IKDC or WOMAC scores between the 2 groups. All IKDC and WOMAC scores for both the PRP and BMC groups significantly improved from baseline to 1 month after the injection ( P < .001). These improvements were sustained for 12 months after the injection, with no difference between PRP and BMC at any time point. Conclusion: Both PRP and BMC were effective in improving patient-reported outcomes in patients with mild to moderate knee OA for at least 12 months; neither treatment provided a superior clinical benefit. Autologous PRP and BMC showed promising clinical potential as therapeutic agents for the treatment of OA, and while PRP has strong clinical evidence to support its efficacy, BMC has limited support. This study did not prove BMC to be superior to PRP, providing guidance to clinicians treating OA. It is possible that the results were affected by patients knowing that there was no control group. Registration: NCT03289416 ( ClinicalTrials.gov identifier).